Emmanuel J Favaloro/LinkedIn
Jan 17, 2026, 04:58
Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
Emmanuel J Favaloro, Lead Scientist of Sydney Centres for Thrombosis and Haemostasis, shared on LinkedIn:
“A Review of Desmopressin Use in Bleeding Disorders. Nearly 5000 article views in only 6 months. Aiming for 10,000 by it’s one year anniversary.
Free to download from here .”
Title: A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Jun 21, 2026, 19:19Tribikram Panda: Ensuring Global Equity in Management of Sickle Cell Disease
-
Jun 21, 2026, 19:15Vicken Babikian Receives Mkhitar Heratsi Medal – AAHPO
-
Jun 21, 2026, 19:11Joaqim Meireles-Brandao: Once Disease is Established, All That Remains is to Mitigate the Consequences
-
Jun 21, 2026, 18:54A Comprehensive Review of Hemophilia A and B – Journal of Thrombosis and Haemostasis
-
Jun 21, 2026, 18:54Maxime Dely: Raising Awareness and Improving Diagnosis of Sickle Cell Disease in France
-
Jun 21, 2026, 18:08Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
-
Jun 21, 2026, 17:59Fakhrul Abedin Jon: Exploring Types of Brain Bleeding
-
Jun 21, 2026, 17:00Jeffrey Schnur: Advanced Treatment Strategies for Deep Vein Thrombosis and Pulmonary Embolism
-
Jun 21, 2026, 16:53Matteo Foschi: When Should We Restart Anticoagulation After a Breakthrough Ischemic Stroke?